These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28166802)

  • 1. Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.
    Kaulfuß M; Wensing I; Windmann S; Hrycak CP; Bayer W
    Retrovirology; 2017 Feb; 14(1):8. PubMed ID: 28166802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of retroviral envelope with vaccine-induced CD8
    Bongard N; Lapuente D; Windmann S; Dittmer U; Tenbusch M; Bayer W
    Retrovirology; 2017 Apr; 14(1):28. PubMed ID: 28449719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodominance of Adenovirus-Derived CD8
    Schöne D; Hrycak CP; Windmann S; Lapuente D; Dittmer U; Tenbusch M; Bayer W
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
    Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
    PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
    Hrycak CP; Windmann S; Bayer W
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.
    Bayer W; Tenbusch M; Lietz R; Johrden L; Schimmer S; Uberla K; Dittmer U; Wildner O
    J Virol; 2010 Feb; 84(4):1967-76. PubMed ID: 20007267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.
    Bayer W; Lietz R; Ontikatze T; Johrden L; Tenbusch M; Nabi G; Schimmer S; Groitl P; Wolf H; Berry CM; Uberla K; Dittmer U; Wildner O
    Retrovirology; 2011 Sep; 8():75. PubMed ID: 21943056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies.
    Bayer W; Schimmer S; Hoffmann D; Dittmer U; Wildner O
    Vaccine; 2008 Jan; 26(5):716-26. PubMed ID: 18160188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-immunization of mice with a retroviral DNA vaccine and GITRL-encoding plasmid augments vaccine-induced protection against retrovirus infection.
    Dittmer U; Werner T; Kraft AR
    Viral Immunol; 2008 Dec; 21(4):459-67. PubMed ID: 19115935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
    Dittmer U; Hasenkrug KJ
    Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection.
    Ohs I; Windmann S; Wildner O; Dittmer U; Bayer W
    PLoS One; 2013; 8(12):e82528. PubMed ID: 24349306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.
    Knuschke T; Rotan O; Bayer W; Sokolova V; Hansen W; Sparwasser T; Dittmer U; Epple M; Buer J; Westendorf AM
    Retrovirology; 2016 Apr; 13():24. PubMed ID: 27076190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus.
    Ruan KS; Lilly F
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12202-6. PubMed ID: 1465459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
    Sugahara D; Tsuji-Kawahara S; Miyazawa M
    J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.
    Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U
    Vaccine; 2004 Jul; 22(21-22):2686-9. PubMed ID: 15246598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.
    Dittmer U; Peterson KE; Messer R; Stromnes IM; Race B; Hasenkrug KJ
    J Virol; 2001 Jan; 75(2):654-60. PubMed ID: 11134279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
    Warimwe GM; Lorenzo G; Lopez-Gil E; Reyes-Sandoval A; Cottingham MG; Spencer AJ; Collins KA; Dicks MD; Milicic A; Lall A; Furze J; Turner AV; Hill AV; Brun A; Gilbert SC
    Virol J; 2013 Dec; 10():349. PubMed ID: 24304565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
    Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
    J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
    Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B
    Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.